Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRUX
Columbia Core Bond ETF
CRUX
|
+$707M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$684M |
| 3 |
Micron Technology
MU
|
+$655M |
| 4 |
EOG Resources
EOG
|
+$556M |
| 5 |
Broadcom
AVGO
|
+$511M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.1B |
| 2 |
Visa
V
|
+$870M |
| 3 |
Bloom Energy
BE
|
+$845M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$809M |
| 5 |
Microsoft
MSFT
|
+$723M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.89% |
| 2 | Financials | 10.23% |
| 3 | Industrials | 8.46% |
| 4 | Healthcare | 7.99% |
| 5 | Consumer Discretionary | 6.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DRUG
2601
Bright Minds Biosciences
DRUG
$706M
| $3.65M | ﹤0.01% |
+50,027
| New | +$4.03M |
|
2602
Pathward Financial
CASH
$1.82B
| $3.63M | ﹤0.01% |
40,694
-6,298
| -13% | -$548K |
|
|
AVR
2603
Anteris Technologies
AVR
$795M
| $3.63M | ﹤0.01% |
+653,330
| New | +$3.75M |
|
2604
BellRing Brands
BRBR
$1.52B
| $3.62M | ﹤0.01% |
225,197
-7,322
| -3% | -$148K |
|
2605
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.77B
| $3.62M | ﹤0.01% |
78,928
+1,472
| +2% | +$70.2K |
|
2606
Invesco BulletShares 2032 Corporate Bond ETF
BSCW
$1.48B
| $3.6M | ﹤0.01% |
174,894
+26,858
| +18% | +$560K |
|
2607
Universal Electronics
UEIC
$57.6M
| $3.6M | ﹤0.01% |
873,651
+9,995
| +1% | +$39.7K |
|
2608
Takeda Pharmaceutical
TAK
$55.7B
| $3.59M | ﹤0.01% |
194,037
+13,902
| +8% | +$244K |
|
2609
Bowman Consulting
BWMN
$459M
| $3.58M | ﹤0.01% |
126,022
-3,768
| -3% | -$123K |
|
2610
iShares Emerging Markets Dividend ETF
DVYE
$1.2B
| $3.58M | ﹤0.01% |
104,087
+43,272
| +71% | +$1.46M |
|
2611
Capital Group Core Plus Income ETF
CGCP
$8.39B
| $3.58M | ﹤0.01% |
160,160
-17,268
| -10% | -$391K |
|
2612
AB InBev
BUD
$156B
| $3.58M | ﹤0.01% |
51,573
+4,723
| +10% | +$341K |
|
2613
Pitney Bowes
PBI
$2.46B
| $3.57M | ﹤0.01% |
323,302
-84,888
| -21% | -$891K |
|
2614
ManpowerGroup
MAN
$2.5B
| $3.57M | ﹤0.01% |
121,251
-3,143
| -3% | -$93.4K |
|
2615
Thomson Reuters
TRI
$42.7B
| $3.56M | ﹤0.01% |
37,309
-9,568
| -20% | -$1.01M |
|
2616
NBT Bancorp
NBTB
$2.73B
| $3.56M | ﹤0.01% |
83,504
-4,377
| -5% | -$190K |
|
|
TSI
2617
TCW Strategic Income Fund
TSI
$213M
| $3.55M | ﹤0.01% |
791,474
-21,029
| -3% | -$99.6K |
|
2618
Relay Therapeutics
RLAY
$4.06B
| $3.55M | ﹤0.01% |
+356,924
| New | +$3.19M |
|
2619
Vir Biotechnology
VIR
$1.48B
| $3.54M | ﹤0.01% |
395,038
-336,269
| -46% | -$2.68M |
|
2620
Dime Commercial Bancshares
DCOM
$1.77B
| $3.53M | ﹤0.01% |
104,360
-16,503
| -14% | -$542K |
|
2621
Lloyds Banking Group
LYG
$89B
| $3.53M | ﹤0.01% |
701,556
+1,224
| +0.2% | +$6.71K |
|
2622
StoneCo
STNE
$2.65B
| $3.52M | ﹤0.01% |
249,414
-16,645
| -6% | -$256K |
|
2623
Perrigo
PRGO
$1.4B
| $3.51M | ﹤0.01% |
326,398
+20,623
| +7% | +$267K |
|
2624
Invesco Municipal Income Opportunities Trust
OIA
$293M
| $3.5M | ﹤0.01% |
570,680
+8,421
| +1% | +$52.1K |
|
2625
Camping World
CWH
$389M
| $3.5M | ﹤0.01% |
+511,509
| New | +$5.27M |
|
Similar funds
Ameriprise's Q1 2026 Portfolio in Review
As of Q1 2026, Ameriprise held 4,261 positions worth $432B, down 2.4% from $443B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ameriprise's Q1 2026 filing shows 190 new, 1,715 increased, 2,050 reduced and 216 closed positions. Its largest new stake was Columbia Core Bond ETF: 23,603,545 shares worth $709M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.1B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.
- Ameriprise's largest Q1 2026 buy was Columbia Core Bond ETF: 23,603,545 shares worth $709M.
- Ameriprise added most to Berkshire Hathaway Class B in Q1 2026, an estimated $684M increase.
- Ameriprise's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.1B.
- Ameriprise fully exited Exact Sciences in Q1 2026, selling an estimated $174M.
- Ameriprise's ten largest holdings make up 19% of its $432B portfolio in Q1 2026.
- Ameriprise opened 190 new positions and closed 216 in Q1 2026.
- Ameriprise's portfolio value fell 2.4% quarter-over-quarter to $432B.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.